Taeniasis
📧 Sign up to get email alerts when something new happens for Taeniasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-12-19FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for Biltricide (praziquantel) to update the label with expanded indications for treating helminth in…
-
FDA approval · 2019-01-08FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for Biltricide (praziquantel) from Bayer HealthCare Pharmaceuticals Inc. This approval results in an…
-
CLINICAL_TRIALS withdrawal · 2016-08-30Clinical Trial Update: Single Ascending Dose Safety Study of Oxfendazole [Phase 1]
The clinical trial update indicates that a Phase 1 single ascending dose safety study of oxfendazole for Taenia solium infection has been wi…
-
FDA approval · 2014-11-20FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for Biltricide (praziquantel) from Bayer HealthCare Pharmaceuticals Inc., authorizing changes to the…
-
FDA approval · 2014-02-25FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for Biltricide (praziquantel) from Bayer HealthCare Pharmaceuticals, authorizing changes to the prod…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-08-16FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for Biltricide (praziquantel) filed by Bayer HealthCare Pharmaceuticals Inc., updating the produ…